Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

Wearable Ultrasound Patch Does Continuous Fetal Monitoring

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

Femoral BMD May Reflect Broader Health in Older Women

An observational study suggests that bone mineral density may serve as a marker of systemic health.

US FDA Extends Review Of AstraZeneca’s Experimental Breast Cancer Pill

AstraZeneca said on Wednesday the U.S. Food and Drug Administration has extended ⁠the decision deadline for the drugmaker's experimental breast cancer pill camizestrant to...

Cesarean Birth Raises Postpartum Psychiatric Risk

Cesarean deliveries, whether planned or unplanned, are associated with an increased risk for new postpartum psychiatric conditions compared with spontaneous vaginal births.

Some Midwives Break the Law To Assist With Home Births

Midwives are helping more Georgia families with home births even though the practice is illegal, as demand rises and lawmakers clash over whether to legalize and regulate it.

In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures

In addition to reducing OR burden and its accompanying costs, offering nitrous oxide for in-office procedures can be easier for patients.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

An observational study suggests that bone mineral density may serve as a marker of systemic health.

AstraZeneca said on Wednesday the U.S. Food and Drug Administration has extended ⁠the decision deadline for the drugmaker's experimental breast cancer pill camizestrant to...

Cesarean deliveries, whether planned or unplanned, are associated with an increased risk for new postpartum psychiatric conditions compared with spontaneous vaginal births.

Midwives are helping more Georgia families with home births even though the practice is illegal, as demand rises and lawmakers clash over whether to legalize and regulate it.

In addition to reducing OR burden and its accompanying costs, offering nitrous oxide for in-office procedures can be easier for patients.

News All Time

ACOG: American College of Obstetricians and Gynecologists

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

TMS: The Menopause Society

ASRM: American Society for Reproductive Medicine

SMFM: Society for Maternal-Fetal Medicine

SGO: Society of Gynecologic Oncology

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in GTN

HHS Changing Its Tune on Contraceptive Access

Focus of Title X program shifting to "natural family planning" and encouragement of pregnancy

DOJ Fires Prosecutors Accused of Bias Against Anti-Abortion Activists

They are the latest wave of terminations of those involved in cases criticized by conservatives

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

The plea was unexpected

'Something Is Wrong': Don't Dismiss Pregnant Patients

Bias often shapes whose voices we prioritize and whose we question

Medical Board Sanctions Docs for Delayed Care That Led to Deaths of 2 Pregnant Women

Reproductive rights advocates said Texas board should do more

Advanced Ovarian Cancer Responds to Claudin-Targeted Drug in Preliminary Trial

Partial responses in half of patients with platinum-resistant disease, as crowded ADC list grows

Study on Maternal RSV Vaccine Flags Possible Risk, Calls for More Research

Analyses unable to rule out potential increase in pregnancy-associated hypertensive disorders

Kennedy Tangles With Lawmakers Over Vitamin K Shots, Vaccines for Newborns

"I've never been anti-vax," the health secretary said

Giving Flu, Pertussis Shots on the Same Day Likely Safe in Pregnancy

Pregnancy, birth, neonatal outcomes similar to when giving a single shot

Recommended News For You

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

FDA Expands Approval of Osimertinib in Lung Cancer

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

3D virtual staining technology enables non-invasive observation of cancer tissue

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

Recommended Articles For You

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology 

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role 

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

2.

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

3.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

4.

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

5.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

1.

How to Prevent Tumor Lysis Syndrome in Cancer Patients

2.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

3.

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

4.

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide 

5.

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot